Search - tctmd.com

Displaying 141 - 160 of 181

Sort: Relevancy | Date

News Daily News

TAVR’s Two-Surgeon Sign-off Rule Must Go, Experts Say

Shelley Wood

July 23, 2018

News Daily News

Discharge Against Medical Advice After PCI Rare but Deadly

Michael O'Riordan

July 17, 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

Gender-neutral criteria and better transparency around physician salaries are among proposals under consideration as a draft resolution moves ahead.

News Daily News

AMA Takes on Gender Inequity, Including the Wage Gap

Michael O'Riordan

June 15, 2018

News Daily News

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

Michael O'Riordan

June 07, 2018

News Conference News CRT 2018

Radial Access PCI Reduces Risk of Mortality and Bleeding in VALIDATE-SWEDEHEART

Michael O'Riordan

March 06, 2018

News Features

Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks?

L.A. McKeown

February 26, 2018

News Daily News

Efficiency Improvements Increase Cath Lab Use as Well as Employee Satisfaction

Yael L. Maxwell

February 02, 2018

News Daily News

Women Have Higher Risk of Unplanned Readmission After PCI

Michael O'Riordan

January 12, 2018

News Daily News

Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed

Michael O'Riordan

January 10, 2018

News Daily News

Ten Principles for Successful Treatment of HF With Reduced EF: New ACC Decision Pathway

Michael O'Riordan

January 02, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Conference News AHA 2017

Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality

Michael O'Riordan

November 14, 2017

News Conference News AHA 2017

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Michael O'Riordan

November 12, 2017

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

News Features

Conference Organizers, Physicians Wary as Direct Industry Sponsorship Winds Down in Europe

Todd Neale

October 16, 2017

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

News Daily News

Generic ARBs Linked to Increased Adverse Events

Michael O'Riordan

October 04, 2017

News Daily News

New Performance and Quality Metrics for STEMI and NSTEMI Care

Michael O'Riordan

September 21, 2017

News Daily News

Evolocumab Not Cost-Effective at Current List Price

Michael O'Riordan

August 23, 2017

Advertisement

TAVR’s Two-Surgeon Sign-off Rule Must Go, Experts Say

Discharge Against Medical Advice After PCI Rare but Deadly

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

AMA Takes on Gender Inequity, Including the Wage Gap

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

Radial Access PCI Reduces Risk of Mortality and Bleeding in VALIDATE-SWEDEHEART

Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks?

Efficiency Improvements Increase Cath Lab Use as Well as Employee Satisfaction

Women Have Higher Risk of Unplanned Readmission After PCI

Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed

Ten Principles for Successful Treatment of HF With Reduced EF: New ACC Decision Pathway

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Conference Organizers, Physicians Wary as Direct Industry Sponsorship Winds Down in Europe

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Generic ARBs Linked to Increased Adverse Events

New Performance and Quality Metrics for STEMI and NSTEMI Care

Evolocumab Not Cost-Effective at Current List Price

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content